Leileata M Russo

Title: Leileata M Russo: Innovator in Nucleic Acid Extraction

Introduction

Leileata M Russo is a prominent inventor based in New York, NY, known for his significant contributions to the field of nucleic acid extraction. With a total of seven patents to his name, Russo has developed innovative methods that enhance the efficiency and reliability of nucleic acid isolation from biological samples.

Latest Patents

Among his latest patents is a method for the isolation of nucleic acid-containing particles and the extraction of nucleic acids therefrom. This method involves isolating nucleic acid-containing particles through one or more centrifugation procedures, which are performed at speeds not exceeding about 200,000 g. The extracted nucleic acids include both 18S and 28S rRNA, ensuring high-quality results. Another notable patent focuses on controls for nucleic acid assays, featuring a method and kit for isolating microvesicles or extracting microvesicle nucleic acids from biological samples using control particles. These control particles, which can be viruses or virus-like particles, help assess the accuracy and efficiency of the isolation and extraction processes.

Career Highlights

Leileata M Russo has worked with notable companies such as Exosome Diagnostics, Inc. and The General Hospital Corporation. His work in these organizations has contributed to advancements in medical diagnostics and research.

Collaborations

Throughout his career, Russo has collaborated with esteemed colleagues, including Johan Karl Olov Skog and Wayne Comper. These partnerships have further enriched his research and development efforts in the field of nucleic acids.

Conclusion

Leileata M Russo's innovative work in nucleic acid extraction has made a significant impact on the field of molecular biology. His patents reflect a commitment to improving the accuracy and efficiency of nucleic acid assays, which are crucial for medical diagnostics and research.